Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
AVEO PHARMA
(NQ:
AVEO
)
2.700
USD
+0.040 (+1.50%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
2.680
Bid (Size)
2.690 (25000)
Ask (Size)
2.700 (7100)
Prev. Close
2.660
Today's Range
2.550 - 2.740
52wk Range
2.250 - 14.08
Shares Outstanding
51,885,668
Dividend Yield
N/A
Top News
More News
Streetinsider.com After-Hours Movers 05/23: (BLOX) (P) (MRVL) Higher; (SHLD) (AVEO) (CRM)
Today 17:43 EDT
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8367336 for the full story.
Read More
from
StreetInsider.com News Articles
Aveo says partner Astellas will not seek EU nod for kidney cancer drug
Today 17:39 EDT
May 23 (Reuters) - Aveo Pharmaceuticals Inc said it was informed by its partner Astellas Pharma Inc that the Japanese company would not be seeking marketing approval for their experimental kidney...
Read More
category
companyNews
from
Reuters: Company News
More News
Read More
AVEO Pharma (AVEO) Says Partner Astellas Won't Submit Tivozani to EMA, Won't Fund Future Trials
Today 16:25 EDT
from
StreetInsider.com News Articles
Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
May 22, 2013
from
PR Newswire
Law Offices of Todd M. Garber Announces Investigation of AVEO Pharmaceuticals, Inc.
May 20, 2013
from
Business Wire News Releases
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
May 18, 2013
from
PR Newswire
Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- AVEO
May 17, 2013
from
GlobeNewswire News Releases
Aveo Pharmaceuticals, Inc. Sued by Investor
May 17, 2013
from
PR Newswire
Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
May 17, 2013
from
StreetInsider.com News Articles
AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting
May 15, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here